等待开盘 12-18 09:30:00 美东时间
0.000
0.00%
Altimmune Inc. announced that Vipin Garg, Ph.D., will step down as CEO effective January 1, 2026, after seven years of leadership. Jerry Durso, the company’s chairman, will succeed him. Garg will serve as an advisor until June 2026. Durso brings over 30 years of experience in life sciences, including leading Intercept Pharmaceuticals and Sanofi. Garg’s tenure saw the advancement of pemvidutide, a dual glucagon/GLP-1 receptor agonist, into Phase 3...
12-01 12:30
Biotech experts Mark Pruzanski and Andrew Roberts have stepped into new roles a...
10-17 15:00
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 上市公司花了1.25亿元研发的仿制药,上市申请被否!仿制对象已“翻车”:因安...
10-14 12:55
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, in...
08-21 19:03
Arvinas (NASDAQ:ARVN) on Monday announced the appointment of Andrew Saik to the role of Chief Financial Officer and Treasurer. Saik, most recently, served as CFO at Intercept Pharmaceuticals. Prior to...
2024-06-25 04:41
·Rezdiffra是40年来首款获FDA批准上市的MASH药物。过去十年,MASH一直是药物研发热点,但由于发病机制复杂,进展寥寥。辉瑞、百时美施贵宝、吉利德...
2024-03-18 08:34
Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule...
2024-01-17 06:01
全球领先的先进锂离子电池制造商LG能源解决方案(LG Energy Solution)和全球领先的公共交通重型电池系统供应商Impact Clean Powe...
2023-12-08 14:48
Matthew Cullen Joins as Vice President of Value and Access Lisa DeFrancesco Joi...
2023-11-01 04:01
越来越多的明星biotech,选择“退出”创新药市场。 Mirati是最新的卖身者。然而,与大部分biotech由于弹尽粮绝、身处险境而寻求卖身不同,Mira...
2023-10-10 08:04